Christine Desmedt received her bio-engineer degree in Cells and Genes Biotechnology from the Catholic University of Leuven, Belgium, in 2000. Since then she is working at the Jules Bordet Institute, an autonomous comprehensive cancer centre devoted entirely to the fight against cancer. For two years she worked as a clinical monitor for the Breast European Adjuvant Studies Group (Br.E.A.S.T), co-coordinating the monitoring activities of external groups for the conduct of breast cancer trials. In 2002, she joined the Functional Genomics & Translational Research Unit of the Bordet Institute, where she is currently coordinating different research programs. In 2004 she earned a master in bio-medical sciences at the Free University of Brussels and her work is supported by a grant from the ?Fonds National de la Recherche Scientifique?.
Her current research projects, conducted in collaboration with different international institutions, involve the identification and validation of prognostic and predictive markers in breast cancer, as well as a better characterization of breast cancer development and metastasis.
